Skip to main content
Publications
Winfree KB, Ainsworth C, Njue A, Molife C, Lyall M, Jen M-H, Bittoni M, Heyes A, Carbone DP. Defining aggressive disease in patients with advanced NSCLC receiving second-line treatment: a systematic review. Poster presented at the IASLC 19th World Conference on Lung Cancer; September 26, 2018. Toronto, Canada. [abstract] J Thorac Oncol. 2018 Oct; 13(10 (Suppl)):5908. doi: 10.1016/j.jtho.2018.08.1671
Mauskopf J, Chirila C, Graham J, Gersten ID, Leather H, Maziarz RT, Baden LR, Bolanos-Meade J, Brown JMY, Walsh TJ, Horowitz MH, Kurtzberg J, Marr KA, Wingard JR. Comparative cost-effectiveness analysis of voriconazole and fluconazole for prevention of invasive fungal infection in patients receiving allogeneic hematopoietic cell transplants. Am J Health Syst Pharm. 2013 Sep;70(17):1518-27.
Payne JR, Eleftheriou KI, James LE, Hawe E, Mann J, Stronge A, Kotwinski P, World M, Humphries SE, Pennell DJ, Montgomery HE. Left ventricular growth response to exercise and cigarette smoking: data from LARGE Heart. Heart. 2006;92(12):1784-8.
Palka P, Lange A, Fleming AD, Starkey IR, Fenn LN, Shaw TRD, Fox KAA, McDicken WN, Sutherland GR. Transmural velocity gradients-A new ultrasonic index for hypertrophic cardiomyopathy hearts. Poster presented at the British Cardiac Society Annual Meeting; May 7, 1996. Glasgow, Scotland. [abstract] Heart. 1996 May 1; 75(5 Suppl 1):21. doi: 10.1136/hrt.75.5_Suppl_1.P6